Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT05883449
Title Phase 2 Study of AFM13 in Combination With AB-101 in Subjects With R/R HL and CD30+ PTCL (LuminICE-203)
Acronym LuminICE-203
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Affimed GmbH
Age Groups: senior | adult
Covered Countries USA

No variant requirements are available.